{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:56:06Z","timestamp":1777600566576,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.nmd.2013.07.010","type":"journal-article","created":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T14:45:34Z","timestamp":1375886734000},"page":"874-882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Muscle specific kinase autoimmune myasthenia gravis in children: A case series"],"prefix":"10.1016","volume":"23","author":[{"given":"Karen L.","family":"Skjei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanda A.","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L.","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2013.07.010_b0005","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0010","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1749-6632.1987.tb51321.x","article-title":"Clinical correlations of antibodies that bind, block or modulate human acetylcholine receptors in myasthenia gravis","volume":"505","author":"Howard","year":"1987","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.nmd.2013.07.010_b0015","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1212\/WNL.43.5.977","article-title":"Acetylcholine receptor antibodies in juvenile myasthenia gravis","volume":"43","author":"Andrews","year":"1993","journal-title":"Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0020","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mus.20854","article-title":"Frequency of seronegativity in adult-acquired generalized myasthenia gravis","volume":"36","author":"Chan","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2013.07.010_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00605.x","article-title":"Immunological disorders of neuromuscular transmission","volume":"113","author":"Vincent","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nmd.2013.07.010_b0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2013.07.010_b0035","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2013.07.010_b0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2013.07.010_b0045","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0896-6273(95)90146-9","article-title":"Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury","volume":"15","author":"Valenzuela","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.nmd.2013.07.010_b0050","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/bies.20305","article-title":"The synaptic muscle-specific kinase (MuSK) complex: new partners, new functions","volume":"7","author":"Strochlic","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.nmd.2013.07.010_b0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1196\/annals.1405.005","article-title":"Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis","volume":"1132","author":"Wolfe","year":"2008","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"10.1016\/j.nmd.2013.07.010_b0060","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2013.07.010_b0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2006.03.016","article-title":"Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)","volume":"175","author":"Jha","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nmd.2013.07.010_b0070","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"Cole","year":"2008","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2013.07.010_b0075","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2013.07.010_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","author":"Viegas","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK-antibody positive myasthenia gravis: a US experience","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2013.07.010_b0090","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/jnnp.2004.052415","article-title":"The features of myasthenia gravis with autoantibodies to MuSK","volume":"76","author":"Lavrnic","year":"2005","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1016\/j.nmd.2013.07.010_b0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/088307389300800422","article-title":"Tests for juvenile myasthenia gravis: comparative diagnostic yield and prediction of outcome","volume":"8","author":"Afifi","year":"1993","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/01.wnl.0000267694.45244.f4","article-title":"Anti-MuSK antibody after thymectomy in a previously seropositive myasthenic child","volume":"69","author":"Saulat","year":"2007","journal-title":"Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0105","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/01.WNL.0000128048.23930.1D","article-title":"Are MuSK antibodies the primary cause of myasthenic symptoms?","volume":"62","author":"Selcen","year":"2004","journal-title":"Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0110","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1468-1331.2009.02624.x","article-title":"Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece","volume":"16","author":"Tsiamalos","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0115","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1468-1331.2008.02176.x","article-title":"MuSK-positive myasthenia gravis is rare in the Polish population","volume":"15","author":"Kostera-Pruszczyk","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.nmd.2008.03.006","article-title":"Severe neonatal myasthenia due to maternal anti-MuSK antibodies","volume":"18","author":"Behin","year":"2008","journal-title":"Neuromus Dis"},{"key":"10.1016\/j.nmd.2013.07.010_b0125","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1212\/01.wnl.0000307751.20968.f1","article-title":"A transient neonatal myasthenic syndrome with anti-MuSK antibodies","volume":"70","author":"Niks","year":"2008","journal-title":"Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/CND.0b013e3181a78280","article-title":"Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis","volume":"11","author":"O\u2019Carroll","year":"2009","journal-title":"J Clin Neuromus Dis"},{"key":"10.1016\/j.nmd.2013.07.010_b0135","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1093\/hmg\/ddh333","article-title":"MuSK, a new target for mutations causing congenital myasthenic syndrome","volume":"13","author":"Chevessier","year":"2004","journal-title":"Human Mol Genet"},{"key":"10.1016\/j.nmd.2013.07.010_b0140","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/WNL.0b013e3181c3fce9","article-title":"Refinement of the clinical phenotype in MuSK-related congenital myasthenic syndromes","volume":"73","author":"Mihaylova","year":"2009","journal-title":"Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0145","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/hmg\/ddq110","article-title":"Mutations in MUSK causing congenital myasthenic syndrome impair MuSK\u2013DOK7 interaction","volume":"19","author":"Masseli","year":"2010","journal-title":"Human Mol Genet"},{"key":"10.1016\/j.nmd.2013.07.010_b0150","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1212\/WNL.44.7.1208","article-title":"Race, sex and puberty influence onset, severity and outcome in juvenile myasthenia gravis","volume":"44","author":"Andrews","year":"1994","journal-title":"Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0155","first-page":"561","article-title":"Juvenile myasthenia gravis with prepubertal onset","volume":"8","author":"Evoli","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2013.07.010_b0160","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/mus.21191","article-title":"Racial differences in myasthenia gravis in Alabama","volume":"39","author":"Oh","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2013.07.010_b0165","unstructured":"Burns T, Wolfe G, Nations S, et al. Variable MuSK antibody positive rates among seronegative MG in the United States. In: AAN 2008 annual meeting; 2008: Chicago, IL."},{"key":"10.1016\/j.nmd.2013.07.010_b0170","unstructured":"Young A, Claussen G, Morgan M, et al. Clinical and laboratory differences among three types of generalized myasthenia Gravis. In: AAN 2008 annual meeting; 2008: Chicago, IL."},{"key":"10.1016\/j.nmd.2013.07.010_b0175","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.410130506","article-title":"Myasthenia Gravis in children: long-term followup","volume":"13","author":"Rodriguez","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0180","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/mus.21195","article-title":"Juvenile myasthenia gravis","volume":"39","author":"Chiang","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2013.07.010_b0185","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1001\/archneur.62.6.1002","article-title":"Anti-MuSK myasthenia gravis presenting with purely ocular findings","volume":"62","author":"Caress","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0190","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.20498","article-title":"Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis","volume":"33","author":"Oh","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2013.07.010_b0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpn.2011.07.014","article-title":"Nerve conduction studies and needle EMG in very small children","volume":"16","author":"Pitt","year":"2012","journal-title":"Eur J Paed Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0200","first-page":"1780","article-title":"Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy","volume":"256","author":"Kostera-Pruszczyk","year":"2009","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"10.1016\/j.nmd.2013.07.010_b0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2008.05.032","article-title":"MuSK-antibody positive myasthenia gravis: questions from the clinic","volume":"201","author":"Sanders","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nmd.2013.07.010_b0210","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1212\/01.WNL.0000129274.12702.92","article-title":"MuSK antibodies in AChR Ab-seropositive MG vs. AChR Ab-seronegative MG","volume":"62","author":"Ohta","year":"2004","journal-title":"Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0215","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0220","unstructured":"Briscoe NK, Mezei MM, Wilson J, et al. Lymphofollicular hyperplasia is rare in both MuSK positive and in seronegative myasthenia gravis. In: AAN 2008 Annual Meeting. 2008: Chicago, IL."},{"key":"10.1016\/j.nmd.2013.07.010_b0225","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0230","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/01.wnl.0000183145.91579.74","article-title":"Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG","volume":"65","author":"Hatanaka","year":"2005","journal-title":"Neurol"},{"key":"10.1016\/j.nmd.2013.07.010_b0235","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"Diaz-Manera","year":"2012","journal-title":"Neurol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613009309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613009309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:01:28Z","timestamp":1760774488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896613009309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0960896613009309"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2013.07.010","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle specific kinase autoimmune myasthenia gravis in children: A case series","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2013.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}